4//SEC Filing
Bhagat Sarah M 4
Accession 0001209191-23-037293
CIK 0001693011other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:05 PM ET
Size
10.2 KB
Accession
0001209191-23-037293
Insider Transaction Report
Form 4
Bhagat Sarah M
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-13+16,000→ 16,000 totalExercise: $6.18Exp: 2033-06-12→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 13, 2023. The shares underlying the option are scheduled to vest as to 100% of the shares on June 13, 2024, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001817762
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:05 PM ET
- Size
- 10.2 KB